SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 70.98 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 61.42 |
| Book Value / Share | 0.91 |
| Price / Book | n/a |
| NCAV ($M) | 57.05 |
| NCAV / Share | 0.84 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.74 |
| Return on Assets (ROA) | -0.43 |
| Return on Equity (ROE) | -0.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.57 |
| Current Ratio | 5.06 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 71.66 |
| Assets | 76.02 |
| Liabilities | 14.60 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.17 |
| Operating Income | -52.01 |
| Net Income | -46.06 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -48.56 |
| Cash from Investing | 52.36 |
| Cash from Financing | 0.39 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,648 | 47,242 | 35.24 | |
| 25,479 | 87,451 | 29.14 | |
| 67,669 | 310,463 | 21.80 | |
| 69,713 | 433,785 | 16.07 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IBRX – ImmunityBio, Inc. | IDXX – IDEXX Laboratories, Inc. |
| IDYA – IDEAYA Biosciences, Inc. | IGMS – IGM Biosciences, Inc. |
| IMUX – Immunic, Inc. |
Financial data and stock pages provided by
Fintel.io